{
  "$schema": "folio-library-document/v1",
  "id": "10665-42988",
  "title": "Plan stratégique de l' Initiative mondiale pour l' éradication de la poliomyélite :  2004-2008",
  "variant": "pdf",
  "pages": 45,
  "tocSource": "undetermined",
  "tocMethod": "contents",
  "toc": [],
  "sections": [
    {
      "id": "page-001",
      "number": null,
      "title": "Page 1",
      "level": 1,
      "pageStart": 1,
      "pageEnd": 1,
      "labelStart": "A",
      "labelEnd": "A",
      "words": 21,
      "summary": {
        "text": "The cover page of the French edition of the Global Polio Eradication Initiative Strategic Plan 2004–2008, issued by WHO and the initiative's partners.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "Plan stratégique de l'Initiative mondiale pour l’éradication de la poliomyélite 2004–2008 OMS Partenaires de l’Initiative mondiale pour l’éradication de la poliomyélite",
      "extractCut": false,
      "blocks": [
        "library/10665-42988/blocks/prose-page-001",
        "library/10665-42988/blocks/figure-img-p001-2"
      ]
    },
    {
      "id": "page-002",
      "number": null,
      "title": "Page 2",
      "level": 1,
      "pageStart": 2,
      "pageEnd": 2,
      "labelStart": "B",
      "labelEnd": "B",
      "words": 343,
      "summary": {
        "text": "The cataloguing and copyright page of the polio eradication strategic plan 2004–2008 (French edition), with ISBN, subject headings, ordering and permissions information and standard disclaimers. It also notes the typesetting and printing in Switzerland.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "organisation mondiale",
          "heading": false
        },
        {
          "term": "adresse électronique",
          "heading": false
        },
        {
          "term": "pour l'éradication",
          "heading": false
        },
        {
          "term": "produits commerciaux",
          "heading": false
        },
        {
          "term": "présente publication",
          "heading": false
        },
        {
          "term": "suisse",
          "heading": false
        },
        {
          "term": "santé",
          "heading": false
        },
        {
          "term": "télécopie",
          "heading": false
        }
      ],
      "extract": "Catalogage à la source : Bibliothèque de l’OMS Initiative mondiale pour l'éradication de la poliomyélite. Plan stratégique de l'Initiative mondiale pour l'éradication de la poliomyélite : 2004-2008. 1. Poliomyélite antérieure aiguë - prévention et contrôle 2. Vaccin antipoliomyélitique Sabin - ressources et distribution 3. Programmes de vaccination - organisation et administration 4. Planification stratégique",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-002"
      ]
    },
    {
      "id": "page-003",
      "number": null,
      "title": "Page 3",
      "level": 1,
      "pageStart": 3,
      "pageEnd": 3,
      "labelStart": "1",
      "labelEnd": "1",
      "words": 11,
      "summary": {
        "text": "The title page of the Global Polio Eradication Initiative Strategic Plan 2004–2008 (French edition).",
        "status": "draft"
      },
      "keywords": [],
      "extract": "Plan stratégique de l'Initiative mondiale pour l’éradication de la poliomyélite 2004–2008",
      "extractCut": false,
      "blocks": [
        "library/10665-42988/blocks/prose-page-003"
      ]
    },
    {
      "id": "page-004",
      "number": null,
      "title": "Page 4",
      "level": 1,
      "pageStart": 4,
      "pageEnd": 4,
      "labelStart": "2",
      "labelEnd": "2",
      "words": 202,
      "summary": {
        "text": "The table of contents of the polio eradication strategic plan (in French), listing the summary, history, goal, four objectives, general challenges, partners' roles and the post-2008 phase of stopping oral polio vaccination.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "phase arrêt",
          "heading": false
        },
        {
          "term": "mondiale pour",
          "heading": false
        },
        {
          "term": "initiative mondiale",
          "heading": false
        },
        {
          "term": "vpo dans",
          "heading": false
        },
        {
          "term": "vaccination par",
          "heading": false
        }
      ],
      "extract": "2 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 Sigles et acronymes 3 1 Résumé 4 2 Historique 6 3 But 8 4 Objectifs et étapes 9 4.1 Objectif Nº 1 : Interrompre la transmission du poliovirus 9 4.2 Objectif Nº 2 : Parvenir à la certification de l’éradication mondiale de la poliomyélite 18 4.3 Objectif Nº 3 : Mettre au point des produits pour la phase d’arrêt de la",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-004"
      ]
    },
    {
      "id": "page-005",
      "number": null,
      "title": "Page 5",
      "level": 1,
      "pageStart": 5,
      "pageEnd": 5,
      "labelStart": "3",
      "labelEnd": "3",
      "words": 139,
      "summary": {
        "text": "A list of acronyms used in the polio eradication strategic plan (in French), such as donor agencies, national and local immunization days and vaccine types.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "des journées",
          "heading": false
        },
        {
          "term": "journées locales",
          "heading": false
        },
        {
          "term": "journées nationales",
          "heading": false
        },
        {
          "term": "intensifiées occasion",
          "heading": false
        },
        {
          "term": "vaccin antipoliomyélitique",
          "heading": false
        },
        {
          "term": "activités intensifiées",
          "heading": false
        }
      ],
      "extract": "3 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 S i g l e s e t a c r o n y m e s ACDI Agence canadienne de Développement international CDC Centers for Disease Control and Prevention des Etats-Unis d’Amérique DFID Department for International Development (Royaume-Uni) JICA Agence japonaise de Coopération internationale JLV Journées locales de vaccination JLVi Activités",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-005"
      ]
    },
    {
      "id": "page-006",
      "number": null,
      "title": "Page 6",
      "level": 1,
      "pageStart": 6,
      "pageEnd": 6,
      "labelStart": "4",
      "labelEnd": "4",
      "words": 736,
      "summary": {
        "text": "The summary of the polio eradication strategic plan (in French), stating that by end-2003 polio remained in only six countries, nearly five million children had been spared paralysis and vitamin A distribution had averted 1.25 million child deaths. It notes potential savings above US$ 1 billion a year and outlines the plan's four objectives, starting with interrupting wild poliovirus transmission. Footnotes list the remaining endemic countries and note that the plan replaces the 2001–2005 plan.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pour éradication",
          "heading": false
        },
        {
          "term": "les activités",
          "heading": false
        },
        {
          "term": "certification mondiale",
          "heading": false
        },
        {
          "term": "les pays",
          "heading": false
        },
        {
          "term": "des activités",
          "heading": false
        },
        {
          "term": "interruption mondiale",
          "heading": false
        },
        {
          "term": "dans les",
          "heading": false
        },
        {
          "term": "pour interrompre",
          "heading": false
        }
      ],
      "extract": "4 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 R é s u m é 1 À la fin de 2003, l’Initiative mondiale pour l’éradication de la poliomyélite, l’entreprise la plus importante lancée jusqu’ici dans le domaine de la santé publique internationale, avait permis d’éliminer la maladie dans tous les pays sauf six1. Près de cinq millions d’enfants qui seraient paralysés si",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-006"
      ]
    },
    {
      "id": "page-007",
      "number": null,
      "title": "Page 7",
      "level": 1,
      "pageStart": 7,
      "pageEnd": 7,
      "labelStart": "5",
      "labelEnd": "5",
      "words": 411,
      "summary": {
        "text": "Continues the summary (in French), describing the products needed to stop oral polio vaccine (OPV) use, such as laboratory containment guidance, monovalent OPV stockpiles and Sabin-strain inactivated vaccine. It describes the fourth objective, integrating polio eradication resources into other disease control programmes, and refers to the separate estimate of financial needs.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pour éradication",
          "heading": false
        },
        {
          "term": "des poliovirus",
          "heading": false
        },
        {
          "term": "les risques",
          "heading": false
        },
        {
          "term": "poliovirus sauvage",
          "heading": false
        },
        {
          "term": "nécessaires pour",
          "heading": false
        },
        {
          "term": "mondiale pour",
          "heading": false
        },
        {
          "term": "les activités",
          "heading": false
        },
        {
          "term": "intégrer les",
          "heading": false
        }
      ],
      "extract": "5 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 danger de la vaccination par le VPO. Ces produits sont notamment les suivants : une troisième édition du Plan d’action mondial de l’OMS pour le confinement des poliovirus sauvages en laboratoire (précisant les exigences à long terme concernant le poliovirus sauvage, les poliovirus dérivés d’une souche vaccinale et les souches",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-007"
      ]
    },
    {
      "id": "page-008",
      "number": null,
      "title": "Page 8",
      "level": 1,
      "pageStart": 8,
      "pageEnd": 8,
      "labelStart": "6",
      "labelEnd": "6",
      "words": 478,
      "summary": {
        "text": "Gives the history of the polio eradication initiative (in French), launched by the World Health Assembly in 1988, and its achievements by the end of 2003. A diagram outlines the plan's timeline to 2009 and beyond, including integration of polio resources and the move to long-term polio vaccination policy.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "organisation mondiale",
          "heading": false
        },
        {
          "term": "mondiale pour",
          "heading": false
        },
        {
          "term": "initiative mondiale",
          "heading": false
        },
        {
          "term": "pour éradication",
          "heading": false
        },
        {
          "term": "des années",
          "heading": false
        },
        {
          "term": "tous les",
          "heading": false
        },
        {
          "term": "phase arrêt",
          "heading": false
        },
        {
          "term": "les pays",
          "heading": false
        }
      ],
      "extract": "6 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 H i s t o r i q u e 2 E N 1988, l’Assemblée mondiale de la Santé, qui réunit chaque année les ministres de la santé de tous les Etats Membres de l’Organisation mondiale de la Santé, a décidé de lancer une action mondiale pour éliminer la poliomyélite. Grâce à l’Initiative mondiale pour l’éradication de la poliomyélite, la",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-008",
        "library/10665-42988/blocks/figure-vfig-p008"
      ]
    },
    {
      "id": "page-009",
      "number": null,
      "title": "Page 9",
      "level": 1,
      "pageStart": 9,
      "pageEnd": 9,
      "labelStart": "7",
      "labelEnd": "7",
      "words": 388,
      "summary": {
        "text": "Continues the history (in French), noting that scaled-up eradication reached over 575 million children with OPV by the late 1990s and that polio has been eliminated from 210 countries and territories. It identifies the last transmission chains in Nigeria, India and Pakistan and presents the plan as the basis for partners' annual planning.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pour éradication",
          "heading": false
        },
        {
          "term": "mondiale pour",
          "heading": false
        },
        {
          "term": "des activités",
          "heading": false
        },
        {
          "term": "pour interrompre",
          "heading": false
        },
        {
          "term": "certification mondiale",
          "heading": false
        },
        {
          "term": "initiative mondiale",
          "heading": false
        },
        {
          "term": "poliovirus sauvage",
          "heading": false
        },
        {
          "term": "plan stratégique",
          "heading": false
        }
      ],
      "extract": "7 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 d’autres faits s’accumulaient pour confirmer, particulièrement dans la Région du Pacifique occidental, la faisabilité opérationnelle des stratégies appliquées initialement dans la Région des Amériques. A partir de la mi-décennie 90, il s’est avéré possible d’amplifier rapidement les activités d’éradication de sorte que, à la",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-009"
      ]
    },
    {
      "id": "page-010",
      "number": null,
      "title": "Page 10",
      "level": 1,
      "pageStart": 10,
      "pageEnd": 10,
      "labelStart": "8",
      "labelEnd": "8",
      "words": 77,
      "summary": {
        "text": "States the goal of the polio eradication initiative (in French): to interrupt poliovirus transmission worldwide, secure the benefits of eradication and use its lessons and infrastructure to strengthen health systems.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "mondiale pour",
          "heading": false
        },
        {
          "term": "initiative mondiale",
          "heading": false
        },
        {
          "term": "éradication",
          "heading": false
        }
      ],
      "extract": "B u t 3 8 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 L E but de l’Initiative mondiale pour l’éradication de la poliomyélite est d’assurer l’interruption de la transmission du poliovirus dans le monde grâce à des mesures nationales et internationales coordonnées, de tirer parti des avantages humanitaires et économiques de l’éradication et d’utiliser les enseignements et",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-010"
      ]
    },
    {
      "id": "page-011",
      "number": null,
      "title": "Page 11",
      "level": 1,
      "pageStart": 11,
      "pageEnd": 11,
      "labelStart": "9",
      "labelEnd": "9",
      "words": 742,
      "summary": {
        "text": "Describes the strategic approach to interrupting wild poliovirus transmission (in French), combining routine and supplementary immunization with high-quality surveillance. It explains why OPV3 coverage alone did not stop polio in many developing countries, including lower seroconversion in tropical settings. It sets out supplementary immunization plans and synchronized campaigns across countries and regions.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "les jnv",
          "heading": false
        },
        {
          "term": "poliovirus sauvage",
          "heading": false
        },
        {
          "term": "des activités",
          "heading": false
        },
        {
          "term": "les pays",
          "heading": false
        },
        {
          "term": "des campagnes",
          "heading": false
        },
        {
          "term": "pays endémie",
          "heading": false
        },
        {
          "term": "pour éradication",
          "heading": false
        },
        {
          "term": "pour interrompre",
          "heading": false
        }
      ],
      "extract": "9 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 Approche stratégique : On s’est efforcé d’interrompre la transmission du poliovirus sauvage en associant des activités de vaccination systématique et des activités de vaccination supplémentaires et en assurant une surveillance de haute qualité (voir aussi la section 4.2). La couverture systématique élevée par trois doses au",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-011"
      ]
    },
    {
      "id": "page-012",
      "number": null,
      "title": "Page 12",
      "level": 1,
      "pageStart": 12,
      "pageEnd": 12,
      "labelStart": "10",
      "labelEnd": "10",
      "words": 695,
      "summary": {
        "text": "Describes how the World Health Assembly and the Technical Consultative Group urged more national and local immunization days, house-to-house vaccination and a focus of resources on the last endemic areas (in French). It plans intensified mass vaccination campaigns to break remaining transmission chains. A map shows wild poliovirus cases and importations as of December 2003.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "poliovirus sauvage",
          "heading": false
        },
        {
          "term": "les zones",
          "heading": false
        },
        {
          "term": "sauvage autochtone",
          "heading": false
        },
        {
          "term": "des zones",
          "heading": false
        },
        {
          "term": "pays endémie",
          "heading": false
        },
        {
          "term": "sauvage type",
          "heading": false
        },
        {
          "term": "les dernières",
          "heading": false
        },
        {
          "term": "dans les",
          "heading": false
        }
      ],
      "extract": "10 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 la Santé a préconisé l’accélération des activités en demandant instamment aux pays d’endémie d’accroître le nombre des JNV organisées chaque année, de prévoir en outre des Journées locales de vaccination (JLV) dans les zones à risque particulièrement élevé et d’introduire une stratégie d’administration du vaccin porte à",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-012",
        "library/10665-42988/blocks/figure-img-p012-1",
        "library/10665-42988/blocks/figure-vfig-p012"
      ]
    },
    {
      "id": "page-013",
      "number": null,
      "title": "Page 13",
      "level": 1,
      "pageStart": 13,
      "pageEnd": 13,
      "labelStart": "11",
      "labelEnd": "11",
      "words": 582,
      "summary": {
        "text": "Explains that transmission persisted because many young children were missed during immunization days and routine OPV coverage was often below 25% in key reservoirs (in French). It notes repeated importations of wild poliovirus that paralysed more than 70 children between 1999 and 2003. A table lists planned national and local immunization days for 2004–2008.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "poliovirus sauvage",
          "heading": false
        },
        {
          "term": "zones endémie",
          "heading": false
        },
        {
          "term": "des zones",
          "heading": false
        },
        {
          "term": "pays endémie",
          "heading": false
        },
        {
          "term": "risque importation",
          "heading": false
        },
        {
          "term": "des opérations",
          "heading": false
        },
        {
          "term": "pays voisins",
          "heading": false
        },
        {
          "term": "occasion des",
          "heading": false
        }
      ],
      "extract": "11 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 Dans toutes les zones d’endémie, si la transmission n’a pas été interrompue c’est parce qu’un grand nombre de jeunes enfants ont échappé aux agents de vaccination à l’occasion des JNV et/ou des JLV qui visaient à fournir des doses de VPO supplémentaires à tous les enfants. Dans la plupart de ces zones, notamment dans les",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-013"
      ]
    },
    {
      "id": "page-014",
      "number": null,
      "title": "Page 14",
      "level": 1,
      "pageStart": 14,
      "pageEnd": 14,
      "labelStart": "12",
      "labelEnd": "12",
      "words": 678,
      "summary": {
        "text": "Focuses on the key reservoir areas in Nigeria, India and Pakistan and the measures needed to reach over 90% of children in intensified campaigns, such as high-level oversight and detailed mapping (in French). It also covers mop-up responses to importations, to be integrated into WHO and UNICEF emergency arrangements by 2007.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "des activités",
          "heading": false
        },
        {
          "term": "ratissage urgence",
          "heading": false
        },
        {
          "term": "poliovirus sauvage",
          "heading": false
        },
        {
          "term": "etats provinces",
          "heading": false
        },
        {
          "term": "poliovirus circulants",
          "heading": false
        },
        {
          "term": "des responsables",
          "heading": false
        },
        {
          "term": "des districts",
          "heading": false
        },
        {
          "term": "que les",
          "heading": false
        }
      ],
      "extract": "12 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 d’endémie – Nigéria, Inde, Pakistan, Niger, Egypte et Afghanistan. Parmi les dernières zones touchées par la transmission endémique du poliovirus sauvage autochtone9, les cinq Etats/provinces réservoirs clés de Kano (Nigéria), de l’Uttar Pradesh et du Bihar (Inde), ainsi que du Sindh et de la Province de la frontière du",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-014"
      ]
    },
    {
      "id": "page-015",
      "number": null,
      "title": "Page 15",
      "level": 1,
      "pageStart": 15,
      "pageEnd": 15,
      "labelStart": "13",
      "labelEnd": "13",
      "words": 555,
      "summary": {
        "text": "Describes supplementary immunization in polio-free areas most at risk of reinfection, including campaigns for two years after the last case in endemic countries (in French). It lists high-risk polio-free countries and a table of routine OPV3 coverage against the target of 90% national coverage by 2010.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "couverture vaccinale",
          "heading": false
        },
        {
          "term": "pays endémie",
          "heading": false
        },
        {
          "term": "république démocratique",
          "heading": false
        },
        {
          "term": "des pays",
          "heading": false
        },
        {
          "term": "couverture par",
          "heading": false
        },
        {
          "term": "une couverture",
          "heading": false
        },
        {
          "term": "organisées dans",
          "heading": false
        },
        {
          "term": "poliovirus sauvage",
          "heading": false
        }
      ],
      "extract": "13 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 3. Vaccination supplémentaire dans les zones exemptes de poliomyélite les plus exposées : La troisième priorité de l’Initiative mondiale pour l’éradication de la poliomyélite consistera à éviter la réimplantation de la transmission du poliovirus sauvage dans les zones libérées de la maladie, surtout à l’intérieur même des",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-015"
      ]
    },
    {
      "id": "page-016",
      "number": null,
      "title": "Page 16",
      "level": 1,
      "pageStart": 16,
      "pageEnd": 16,
      "labelStart": "14",
      "labelEnd": "14",
      "words": 716,
      "summary": {
        "text": "Describes strengthening routine immunization with UNICEF and GAVI to limit spread of imported cases and vaccine-derived polioviruses, including a birth dose of OPV (in French). It gives a table of milestones for interrupting transmission, based on interrupting transmission by early 2005 and the Alliance's coverage target.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "poliovirus circulants",
          "heading": false
        },
        {
          "term": "les zones",
          "heading": false
        },
        {
          "term": "circulants dérivés",
          "heading": false
        },
        {
          "term": "pourcentage des",
          "heading": false
        },
        {
          "term": "dans les",
          "heading": false
        },
        {
          "term": "les pays",
          "heading": false
        },
        {
          "term": "vaccinale systématique",
          "heading": false
        },
        {
          "term": "couverture vaccinale",
          "heading": false
        }
      ],
      "extract": "14 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 l’UNICEF, surtout dans le cadre de l’Alliance mondiale pour les vaccins et la vaccination (GAVI) afin d’améliorer la couverture vaccinale systématique. Dans les zones exemptes de poliomyélite, le renforcement de la couverture vaccinale systématique sera déterminant pour limiter la propagation des cas importés et/ou",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-016"
      ]
    },
    {
      "id": "page-017",
      "number": null,
      "title": "Page 17",
      "level": 1,
      "pageStart": 17,
      "pageEnd": 17,
      "labelStart": "15",
      "labelEnd": "15",
      "words": 798,
      "summary": {
        "text": "Sets out the main challenges to interrupting wild poliovirus transmission by end-2004 (in French), noting evidence in mid-2003 that this could be achieved within a year. It discusses the need for better campaign quality, local political engagement and resources in remaining endemic areas, with a footnote defining the immunity gap.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "interrompue dans",
          "heading": false
        },
        {
          "term": "été interrompue",
          "heading": false
        },
        {
          "term": "les enfants",
          "heading": false
        },
        {
          "term": "être interrompue",
          "heading": false
        },
        {
          "term": "les zones",
          "heading": false
        },
        {
          "term": "poliovirus sauvage",
          "heading": false
        },
        {
          "term": "mal desservis",
          "heading": false
        },
        {
          "term": "des activités",
          "heading": false
        }
      ],
      "extract": "15 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 Interruption de la transmission du poliovirus sauvage : les principaux enjeux Cette section fournit des données supplémentaires sur les principaux enjeux que pose l’interruption de la transmission du poliovirus au niveau mondial ; les répercussions financières potentielles sont présentées dans l'Estimation des ressources",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-017"
      ]
    },
    {
      "id": "page-018",
      "number": null,
      "title": "Page 18",
      "level": 1,
      "pageStart": 18,
      "pageEnd": 18,
      "labelStart": "16",
      "labelEnd": "16",
      "words": 766,
      "summary": {
        "text": "Continues the challenges (in French), including vaccination teams with at least one woman, better accountability in Pakistan's tribal areas and the serious obstacle of intense transmission in northern Nigeria. It also covers vaccine-derived poliovirus risks and improved surveillance to understand them.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "poliovirus dérivés",
          "heading": false
        },
        {
          "term": "circulants dérivés",
          "heading": false
        },
        {
          "term": "souche vaccinale",
          "heading": false
        },
        {
          "term": "des poliovirus",
          "heading": false
        },
        {
          "term": "les poliovirus",
          "heading": false
        },
        {
          "term": "dérivés une",
          "heading": false
        },
        {
          "term": "des activités",
          "heading": false
        },
        {
          "term": "activités supplémentaires",
          "heading": false
        }
      ],
      "extract": "16 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 nécessaires pour vacciner chaque enfant. Il sera particulièrement important d’appliquer inté- gralement le principe des équipes de vaccination comprenant au moins une femme (l’agent de santé féminin local) pour avoir accès à toutes les communautés et à tous les ménages et trouver les très jeunes enfants non vaccinés les plus",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-018"
      ]
    },
    {
      "id": "page-019",
      "number": null,
      "title": "Page 19",
      "level": 1,
      "pageStart": 19,
      "pageEnd": 19,
      "labelStart": "17",
      "labelEnd": "17",
      "words": 83,
      "summary": {
        "text": "Concludes that circulating vaccine-derived poliovirus events should remain rare despite fewer campaigns, with the Technical Consultative Group to review its recommendations by 2005 (in French).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "supplé mentaires",
          "heading": false
        },
        {
          "term": "circulants dérivés",
          "heading": false
        },
        {
          "term": "poliovirus circulants",
          "heading": false
        },
        {
          "term": "vaccination supplé",
          "heading": false
        }
      ],
      "extract": "17 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 En conséquence, si l’incidence d’événements dus à des poliovirus circulants dérivés d’une souche vaccinale pourrait augmenter à la suite de la réduction des activités de vaccination supplé- mentaires au niveau mondial, ces événements devraient rester rares. Néanmoins, le Groupe consultatif technique (TCG) mondial réexaminera",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-019"
      ]
    },
    {
      "id": "page-020",
      "number": null,
      "title": "Page 20",
      "level": 1,
      "pageStart": 20,
      "pageEnd": 20,
      "labelStart": "18",
      "labelEnd": "18",
      "words": 872,
      "summary": {
        "text": "Describes objective 2, achieving global certification of polio eradication by 2008 (in French), noting that three WHO regions were certified by end-2003. It identifies weaknesses in surveillance and in laboratory containment of wild poliovirus as challenges. It explains the acute flaccid paralysis surveillance standards and refers to the WHO laboratory containment action plan.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "poliovirus sauvage",
          "heading": false
        },
        {
          "term": "sauvage dans",
          "heading": false
        },
        {
          "term": "une certification",
          "heading": false
        },
        {
          "term": "pour les",
          "heading": false
        },
        {
          "term": "les trois",
          "heading": false
        },
        {
          "term": "des laboratoires",
          "heading": false
        },
        {
          "term": "les pays",
          "heading": false
        },
        {
          "term": "par les",
          "heading": false
        }
      ],
      "extract": "18 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 4 . 2 O b j e c t i f N ° 2 : P a r v e n i r à l a c e r t i f i c a t i o n d e l ’ é r a d i c a t i o n m o n d i a l e d e l a p o l i o m y é l i t e L A démarche de certification de l’éradication mondiale de la poliomyélite a été validée par l’expérience des trois Régions de l’OMS certifiées exemptes de la maladie à",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-020"
      ]
    },
    {
      "id": "page-021",
      "number": null,
      "title": "Page 21",
      "level": 1,
      "pageStart": 21,
      "pageEnd": 21,
      "labelStart": "19",
      "labelEnd": "19",
      "words": 681,
      "summary": {
        "text": "Describes biosafety rules for inactivated polio vaccine production after transmission ends and the structure of global, regional and national certification commissions (in French). It analyses the status of certification by region and includes a figure on population in regions by certification status.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "les régions",
          "heading": false
        },
        {
          "term": "les pays",
          "heading": false
        },
        {
          "term": "méditerranée orientale",
          "heading": false
        },
        {
          "term": "des commissions",
          "heading": false
        },
        {
          "term": "été créées",
          "heading": false
        },
        {
          "term": "pas aux",
          "heading": false
        },
        {
          "term": "ont pas",
          "heading": false
        },
        {
          "term": "six régions",
          "heading": false
        }
      ],
      "extract": "19 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 particulières définissant les règles de sécurité bio- logique à appliquer après l’interruption de la transmission du poliovirus sauvage ont été élabo- rées et mises au point définitivement en 2003, en collaboration avec les autorités nationales de réglementation et des spécialistes de la sécurité biologique. La certification",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-021"
      ]
    },
    {
      "id": "page-022",
      "number": null,
      "title": "Page 22",
      "level": 1,
      "pageStart": 22,
      "pageEnd": 22,
      "labelStart": "20",
      "labelEnd": "20",
      "words": 819,
      "summary": {
        "text": "Describes the global polio laboratory network and its quality assurance, with 99% of laboratories WHO-accredited in 2002 (in French). It reports progress in laboratory containment, with 148 countries having started or completed inventories by mid-2003, and plans to maintain network resources, citing resolution WHA52.22.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "des laboratoires",
          "heading": false
        },
        {
          "term": "les laboratoires",
          "heading": false
        },
        {
          "term": "laboratoires existants",
          "heading": false
        },
        {
          "term": "des régions",
          "heading": false
        },
        {
          "term": "pfa dans",
          "heading": false
        },
        {
          "term": "poliovirus sauvage",
          "heading": false
        },
        {
          "term": "pays des",
          "heading": false
        },
        {
          "term": "des échantillons",
          "heading": false
        }
      ],
      "extract": "20 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 spécialisés (7). La qualité du travail des laboratoires est garantie par des contrôles annuels, par un programme officiel d’accréditation et par une évaluation continue à l’aide d’indicateurs types. En 2002, 99 % des laboratoires du réseau étaient agréés par l’OMS ; 100 % des échantillons étaient contrôlés dans un",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-022"
      ]
    },
    {
      "id": "page-023",
      "number": null,
      "title": "Page 23",
      "level": 1,
      "pageStart": 23,
      "pageEnd": 23,
      "labelStart": "21",
      "labelEnd": "21",
      "words": 430,
      "summary": {
        "text": "Maps of acute flaccid paralysis surveillance performance indicators for 2003, showing non-polio AFP rates and adequate stool collection rates by country, with map disclaimers in English and French.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "les limites",
          "heading": false
        },
        {
          "term": "frontières approximatives",
          "heading": false
        },
        {
          "term": "afp surveillance",
          "heading": false
        },
        {
          "term": "leurs frontières",
          "heading": false
        },
        {
          "term": "tracé peut",
          "heading": false
        },
        {
          "term": "accord définitif",
          "heading": false
        },
        {
          "term": "pointillé sur",
          "heading": false
        },
        {
          "term": "appellations figurant",
          "heading": false
        }
      ],
      "extract": "21 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 < 0.5 0.5 -1 > 1 No AFP Surveillance Non-polio AFP rate Adequate stool collection rate < 60% 60% -80% > 80% No AFP Surveillance Data in WHO HQ as of 25 November 2003. The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-023",
        "library/10665-42988/blocks/figure-img-p023-1",
        "library/10665-42988/blocks/figure-img-p023-2",
        "library/10665-42988/blocks/figure-vfig-p023"
      ]
    },
    {
      "id": "page-024",
      "number": null,
      "title": "Page 24",
      "level": 1,
      "pageStart": 24,
      "pageEnd": 24,
      "labelStart": "22",
      "labelEnd": "22",
      "words": 587,
      "summary": {
        "text": "Describes future laboratory network activity and data needs ahead of global certification, and priorities for containing wild and vaccine-derived polioviruses under the 2003 global action plan (in French). It also covers WHO support to certification commissions.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "confinement des",
          "heading": false
        },
        {
          "term": "des poliovirus",
          "heading": false
        },
        {
          "term": "poliovirus sauvage",
          "heading": false
        },
        {
          "term": "certification mondiale",
          "heading": false
        },
        {
          "term": "des commissions",
          "heading": false
        },
        {
          "term": "les activités",
          "heading": false
        },
        {
          "term": "dans les",
          "heading": false
        },
        {
          "term": "supplé mentaires",
          "heading": false
        }
      ],
      "extract": "22 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 réseau mondial mais sont chargés de fonctions beaucoup plus larges continuent d'affecter les ressources humaines, les installations et le matériel suffisant à l’éradication de la poliomyélite. Pendant cette même période, on prévoit que l’activité du réseau de laboratoires va en fait augmenter, puisqu’il faudra répondre aux",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-024"
      ]
    },
    {
      "id": "page-025",
      "number": null,
      "title": "Page 25",
      "level": 1,
      "pageStart": 25,
      "pageEnd": 25,
      "labelStart": "23",
      "labelEnd": "23",
      "words": 292,
      "summary": {
        "text": "A table of indicators and annual milestones for objective 2 (in French), covering certification-standard surveillance, testing in accredited laboratories, containment phases, biosafety for inactivated vaccine production and submission of final certification documents from 2004 to 2008.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "certification régionale",
          "heading": false
        },
        {
          "term": "pourcentage",
          "heading": false
        },
        {
          "term": "phase",
          "heading": false
        },
        {
          "term": "biologique",
          "heading": false
        },
        {
          "term": "produisant",
          "heading": false
        }
      ],
      "extract": "23 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 85 % 100 % 50 % (phase I) ND* 60 % (certification régionale) 2 0 0 4 90 % 100 % 75 % (phase I) ND* 70 % (certification régionale) 2 0 0 5 100 % 100 % 100 % (phase I) ND* 85 % (certification régionale) 2 0 0 6 100 % 100 % 100 % (phase II) 60 % 100 % (certification régionale) 2 0 0 7 100 % 100 % 100 % (phase II +) 100 % 100 %",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-025"
      ]
    },
    {
      "id": "page-026",
      "number": null,
      "title": "Page 26",
      "level": 1,
      "pageStart": 26,
      "pageEnd": 26,
      "labelStart": "24",
      "labelEnd": "24",
      "words": 829,
      "summary": {
        "text": "Describes objective 3, developing products for stopping OPV use globally (in French), explaining that outbreaks of vaccine-derived poliovirus since 2000 show that continued OPV use could threaten eradication. It states that routine OPV use should stop as soon as possible after certification while surveillance and immunity are high. It introduces the policy areas the Technical Consultative Group said must be addressed.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vpo pour",
          "heading": false
        },
        {
          "term": "vpo trivalent",
          "heading": false
        },
        {
          "term": "pour les",
          "heading": false
        },
        {
          "term": "les risques",
          "heading": false
        },
        {
          "term": "des poliovirus",
          "heading": false
        },
        {
          "term": "poliomyélite paralytique",
          "heading": false
        },
        {
          "term": "poliovirus sauvages",
          "heading": false
        },
        {
          "term": "vpo dans",
          "heading": false
        }
      ],
      "extract": "24 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 4 . 3 O b j e c t i f N ° 3 : M e t t r e a u p o i n t d e s p r o d u i t s p o u r l a p h a s e d ’ a r r ê t d e l a v a c c i n a t i o n p a r l e V P O d a n s l e m o n d e D EPUIS 2000, les flambées de poliomyélite provoquées par des poliovirus dérivés d’une souche vaccinale (PDSV) ont montré de façon concluante",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-026"
      ]
    },
    {
      "id": "page-027",
      "number": null,
      "title": "Page 27",
      "level": 1,
      "pageStart": 27,
      "pageEnd": 27,
      "labelStart": "25",
      "labelEnd": "25",
      "words": 787,
      "summary": {
        "text": "Lists four policy areas for stopping OPV (routine immunization, detection and notification of circulating poliovirus, vaccine stockpiles and outbreak response, and long-term containment) and summarises the 1998 expert consultation on stopping polio vaccination (in French). A table estimates risks of paralytic polio after global certification.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "poliomyélite paralytique",
          "heading": false
        },
        {
          "term": "poliovirus sauvage",
          "heading": false
        },
        {
          "term": "vpo dans",
          "heading": false
        },
        {
          "term": "paralytique après",
          "heading": false
        },
        {
          "term": "les risques",
          "heading": false
        },
        {
          "term": "poliovirus circulants",
          "heading": false
        },
        {
          "term": "paralytique associée",
          "heading": false
        },
        {
          "term": "vpi pour",
          "heading": false
        }
      ],
      "extract": "25 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 formuler de nouvelles politiques dans quatre domaines interdépendants : 1) la vaccination systématique ; 2) la détection et la notification des poliovirus circulants, qui sont des questions d’urgence pour la santé publique ; 3) les stocks de vaccin antipoliomyélitique et les mécanismes de riposte aux flambées ; 4) le",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-027"
      ]
    },
    {
      "id": "page-028",
      "number": null,
      "title": "Page 28",
      "level": 1,
      "pageStart": 28,
      "pageEnd": 28,
      "labelStart": "26",
      "labelEnd": "26",
      "words": 898,
      "summary": {
        "text": "Describes public consultations, including a 2002 meeting and a 2003 consultation that concluded vaccine-derived polioviruses pose a real risk for as long as OPV is used (in French). It explains why OPV should be stopped soon after certification, as surveillance and coverage tend to decline once regions are certified.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "poliovirus circulants",
          "heading": false
        },
        {
          "term": "souche vaccinale",
          "heading": false
        },
        {
          "term": "circulants dérivés",
          "heading": false
        },
        {
          "term": "donné les",
          "heading": false
        },
        {
          "term": "d'une souche",
          "heading": false
        },
        {
          "term": "dans les",
          "heading": false
        },
        {
          "term": "les risques",
          "heading": false
        },
        {
          "term": "que les",
          "heading": false
        }
      ],
      "extract": "26 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 Parmi les principaux faits nouveaux dans le domaine des consultations publiques, il convient de mentionner une réunion organisée en 2002 au cours de laquelle de nombreux décideurs venus de divers horizons ont réaffirmé l’espoir exprimé au niveau international, et en particulier par les pays à faible revenu et à revenu",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-028"
      ]
    },
    {
      "id": "page-029",
      "number": null,
      "title": "Page 29",
      "level": 1,
      "pageStart": 29,
      "pageEnd": 29,
      "labelStart": "27",
      "labelEnd": "27",
      "words": 792,
      "summary": {
        "text": "Describes encouraging Sabin-strain inactivated polio vaccine and treating any circulating poliovirus detected after eradication as a public health emergency requiring immediate notification (in French). It also covers aligning AFP reporting with other WHO alert systems and developing a containment plan for the OPV cessation phase.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "poliovirus circulants",
          "heading": false
        },
        {
          "term": "poliovirus sauvage",
          "heading": false
        },
        {
          "term": "des poliovirus",
          "heading": false
        },
        {
          "term": "les poliovirus",
          "heading": false
        },
        {
          "term": "confinement des",
          "heading": false
        },
        {
          "term": "circulants dérivés",
          "heading": false
        },
        {
          "term": "tout poliovirus",
          "heading": false
        },
        {
          "term": "des stocks",
          "heading": false
        }
      ],
      "extract": "27 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 production de VPI à partir de poliovirus sauvages, on encouragera la mise au point de VPI fabriqué à partir de souches atténuées (c’est-à-dire souches Sabin) de poliovirus. 2. Détection et notification des poliovirus circulants : Avec l’élimination de la transmission du poliovirus sauvage dans le monde, la détection de tout",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-029"
      ]
    },
    {
      "id": "page-030",
      "number": null,
      "title": "Page 30",
      "level": 1,
      "pageStart": 30,
      "pageEnd": 30,
      "labelStart": "28",
      "labelEnd": "28",
      "words": 640,
      "summary": {
        "text": "Continues Objective 3 of the French edition of the Global Polio Eradication Initiative Strategic Plan 2004–2008, on preparing products for stopping oral polio vaccine (OPV), describing how a third edition of the laboratory containment action plan will set biosafety standards for Sabin strains and vaccine production sites. It notes that long-term containment monitoring will be harmonized with arrangements for other high-risk pathogens. A table sets yearly milestones from 2004 to 2008 and indicators, such as monovalent OPV stockpiles, licensing Sabin-based inactivated vaccine, integration with the International Health Regulations and OPV cessation.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "mondial alerte",
          "heading": false
        },
        {
          "term": "vpo pour",
          "heading": false
        },
        {
          "term": "des poliovirus",
          "heading": false
        },
        {
          "term": "des stocks",
          "heading": false
        },
        {
          "term": "réseau mondial",
          "heading": false
        },
        {
          "term": "poliovirus circulants",
          "heading": false
        },
        {
          "term": "vpo dans",
          "heading": false
        },
        {
          "term": "introduire des",
          "heading": false
        }
      ],
      "extract": "28 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 de PDSV en laboratoire soient adaptées aux risques. Le Plan servira par ailleurs à définir les normes supplémentaires à adopter dans la perspective de l’arrêt de l’utilisation du VPO pour protéger le personnel des établissements de production du VPI contre une infection subclinique. Contrairement à la deuxième édition du",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-030"
      ]
    },
    {
      "id": "page-031",
      "number": null,
      "title": "Page 31",
      "level": 1,
      "pageStart": 31,
      "pageEnd": 31,
      "labelStart": "29",
      "labelEnd": "29",
      "words": 769,
      "summary": {
        "text": "Introduces Objective 4, integrating the polio eradication initiative into broader health services, noting its support since the mid-1990s for vitamin A distribution, integrated disease surveillance, routine immunization and GAVI activities. It explains how supplementary immunization campaigns were used to add other interventions, upgrade routine services such as the cold chain and training, and build community demand. It adds that coordination bodies such as interagency committees and technical advisory groups have taken on strengthening routine immunization.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "des activités",
          "heading": false
        },
        {
          "term": "pour éradication",
          "heading": false
        },
        {
          "term": "vaccination systématique",
          "heading": false
        },
        {
          "term": "des maladies",
          "heading": false
        },
        {
          "term": "surveillance des",
          "heading": false
        },
        {
          "term": "formation des",
          "heading": false
        },
        {
          "term": "dans les",
          "heading": false
        },
        {
          "term": "des cas",
          "heading": false
        }
      ],
      "extract": "29 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 4 . 4 O b j e c t i f N ° 4 : I n t é g r e r l ’ I n i t i a t i v e m o n d i a l e p o u r l ’ é r a d i c a t i o n d e l a p o l i o m y é l i t e L ’ Initiative mondiale pour l’éradication de la poliomyélite a aidé à assurer d’autres services de santé, en particulier depuis le milieu des années 90, moyennant des",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-031"
      ]
    },
    {
      "id": "page-032",
      "number": null,
      "title": "Page 32",
      "level": 1,
      "pageStart": 32,
      "pageEnd": 32,
      "labelStart": "30",
      "labelEnd": "30",
      "words": 835,
      "summary": {
        "text": "Explains that the polio partnership has invested heavily in staff, infrastructure and institutional arrangements, which should be integrated into national immunization and surveillance systems to support goals such as higher routine coverage and lower measles mortality. Its situation analysis notes that polio technical advisory groups now serve wider immunization work, that national interagency coordinating committees became the channel for GAVI support and a model for the Global Fund, and that polio-funded staff already spend much of their time on other priorities. Footnotes cite the advisory groups and a 2001 WHO survey of polio-funded staff.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pour les",
          "heading": false
        },
        {
          "term": "dans les",
          "heading": false
        },
        {
          "term": "les activités",
          "heading": false
        },
        {
          "term": "les jnv",
          "heading": false
        },
        {
          "term": "lutte contre",
          "heading": false
        },
        {
          "term": "les pays",
          "heading": false
        },
        {
          "term": "des cas",
          "heading": false
        },
        {
          "term": "les vaccins",
          "heading": false
        }
      ],
      "extract": "30 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 Pour mener à bien les activités d’éradication, le Partenariat contre la poliomyélite a beaucoup investi dans les ressources humaines, les infrastructures matérielles et les arrangements institutionnels. Il sera déterminant d’intégrer cet investissement dans les systèmes nationaux de vaccination et de surveillance pour que",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-032"
      ]
    },
    {
      "id": "page-033",
      "number": null,
      "title": "Page 33",
      "level": 1,
      "pageStart": 33,
      "pageEnd": 33,
      "labelStart": "31",
      "labelEnd": "31",
      "words": 753,
      "summary": {
        "text": "Gives examples of integration, such as the acute flaccid paralysis network serving as a base for integrated disease surveillance in the WHO African Region and joint polio and measles surveillance in the Americas, and WHO and UNICEF training of polio-funded staff to support routine immunization. It sets out planned work, beginning with transferring polio-funded human resources and engaging stakeholders. It then describes extending acute flaccid paralysis surveillance to other diseases of public health importance.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "les pays",
          "heading": false
        },
        {
          "term": "des pays",
          "heading": false
        },
        {
          "term": "pour les",
          "heading": false
        },
        {
          "term": "lutte contre",
          "heading": false
        },
        {
          "term": "les maladies",
          "heading": false
        },
        {
          "term": "les campagnes",
          "heading": false
        },
        {
          "term": "des ressources",
          "heading": false
        },
        {
          "term": "vaccination systématique",
          "heading": false
        }
      ],
      "extract": "31 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 y réagir. Dans la Région africaine de l’OMS, le réseau PFA a servi de cadre pour la « surveillance intégrée des maladies ». En 1998, 86 % des pays de cette Région y avaient inclus la rougeole et le tétanos néonatal et 60 % avaient inclus le choléra et la méningite. Aux Amériques, la surveillance de la poliomyélite et de la",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-033"
      ]
    },
    {
      "id": "page-034",
      "number": null,
      "title": "Page 34",
      "level": 1,
      "pageStart": 34,
      "pageEnd": 34,
      "labelStart": "32",
      "labelEnd": "32",
      "words": 782,
      "summary": {
        "text": "Describes two approaches to integrating surveillance: merging acute flaccid paralysis surveillance into routine systems where capacity exists, prioritizing certified polio-free countries, or building it up to cover other vaccine-preventable and epidemic-prone diseases elsewhere. It notes that countries needing long-term surveillance support will be identified by the end of 2004. It also discusses applying polio eradication lessons to other health goals, especially the Millennium Development Goal target on child mortality.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "les maladies",
          "heading": false
        },
        {
          "term": "pour les",
          "heading": false
        },
        {
          "term": "les activités",
          "heading": false
        },
        {
          "term": "les pays",
          "heading": false
        },
        {
          "term": "pour éradication",
          "heading": false
        },
        {
          "term": "dans les",
          "heading": false
        },
        {
          "term": "autres maladies",
          "heading": false
        },
        {
          "term": "intégration des",
          "heading": false
        }
      ],
      "extract": "32 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 des maladies dans les pays où existent structures et moyens, la priorité Nº 1 étant les pays où les systèmes sont les plus développés et qui ont été certifiés exempts de poliomyélite. Dans les pays où ces moyens n’existent pas, le système de surveillance de la PFA sera développé de manière à faciliter détection,",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-034"
      ]
    },
    {
      "id": "page-035",
      "number": null,
      "title": "Page 35",
      "level": 1,
      "pageStart": 35,
      "pageEnd": 35,
      "labelStart": "33",
      "labelEnd": "33",
      "words": 379,
      "summary": {
        "text": "Adds that polio experience in human resources, financing and management should support efforts against measles and the expansion of interventions such as vitamin A, insecticide-treated nets and antiretroviral treatment. A table sets yearly percentage targets from 2004 to 2008 for Objective 4 indicators, such as priority countries implementing integrated plans and full integration of polio operations into measles activities.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pourcentage des",
          "heading": false
        },
        {
          "term": "lutte contre",
          "heading": false
        },
        {
          "term": "des pays",
          "heading": false
        },
        {
          "term": "des ressources",
          "heading": false
        },
        {
          "term": "poliomyélite qui",
          "heading": false
        },
        {
          "term": "les activités",
          "heading": false
        },
        {
          "term": "ressources humaines",
          "heading": false
        }
      ],
      "extract": "33 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 les domaines des ressources humaines, du financement ainsi que de l’administration et de la gestion soit mise à profit pour les activités internationales visant à réduire durablement la mortalité et la morbidité rougeoleuses ainsi qu’à développer la couverture d’interventions de santé telles que la distribution de vitamine",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-035"
      ]
    },
    {
      "id": "page-036",
      "number": null,
      "title": "Page 36",
      "level": 1,
      "pageStart": 36,
      "pageEnd": 36,
      "labelStart": "34",
      "labelEnd": "34",
      "words": 726,
      "summary": {
        "text": "Opens the chapter on general challenges facing polio eradication, starting with the need for sustained high-level political commitment in endemic and donor countries, supported by country-by-country advocacy. It then covers external financing, noting the US$ 150 million needed to interrupt transmission and US$ 380 million for certification and integration in 2004–2005. It recalls the 2003 funding shortfalls that forced activities to be cancelled and describes resource mobilization efforts targeting G8 countries.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pour éradication",
          "heading": false
        },
        {
          "term": "activités éradication",
          "heading": false
        },
        {
          "term": "partenariat pour",
          "heading": false
        },
        {
          "term": "des activités",
          "heading": false
        },
        {
          "term": "pour les",
          "heading": false
        },
        {
          "term": "mobilisation des",
          "heading": false
        },
        {
          "term": "des pays",
          "heading": false
        },
        {
          "term": "poliomyélite est",
          "heading": false
        }
      ],
      "extract": "34 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 E n j e u x g é n é r a u x 5 O UTRE les deux enjeux spécifiques déjà mentionnés auxquels se heurte l’interruption de la transmission du poliovirus, il se pose six grands enjeux qui ont tous à voir avec les quatre objectifs exposés ici. On trouvera dans les paragraphes qui suivent un aperçu de chacun de ces enjeux et des",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-036"
      ]
    },
    {
      "id": "page-037",
      "number": null,
      "title": "Page 37",
      "level": 1,
      "pageStart": 37,
      "pageEnd": 37,
      "labelStart": "35",
      "labelEnd": "35",
      "words": 797,
      "summary": {
        "text": "Discusses the need for a reliable supply of quality polio vaccines, including about 2.5 billion doses of WHO-prequalified OPV for supplementary campaigns in 2004–2005, continued OPV production capacity for stockpiles and growing demand for inactivated vaccine. It then covers conflict-affected countries and areas, where special arrangements will be needed for immunization, certification and staff security. It also introduces communication, advocacy and social mobilization needs in endemic areas and donor countries.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vpo pour",
          "heading": false
        },
        {
          "term": "des zones",
          "heading": false
        },
        {
          "term": "pour les",
          "heading": false
        },
        {
          "term": "pour éradication",
          "heading": false
        },
        {
          "term": "dans les",
          "heading": false
        },
        {
          "term": "les vaccins",
          "heading": false
        },
        {
          "term": "les activités",
          "heading": false
        },
        {
          "term": "vaccins antipoliomyélitiques",
          "heading": false
        }
      ],
      "extract": "35 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 5 . 3 V a c c i n s a n t i p o l i o m y é l i t i q u e s d e q u a l i t é Pour atteindre tous les grands objectifs énoncés dans ce plan, il faudra garantir un approvisionnement fiable en vaccins antipoliomyélitiques de qualité. Pour briser les dernières chaînes de transmission du poliovirus, il faudra environ 2,5",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-037"
      ]
    },
    {
      "id": "page-038",
      "number": null,
      "title": "Page 38",
      "level": 1,
      "pageStart": 38,
      "pageEnd": 38,
      "labelStart": "36",
      "labelEnd": "36",
      "words": 529,
      "summary": {
        "text": "Calls for stronger social mobilization in the last endemic areas to engage communities and counter rumours that have undermined trust, with attention to vaccinator training, inclusion of women and suitable communication materials. It then covers biocontainment, setting deadlines for countries to inventory laboratories holding wild poliovirus by the end of 2004 and to destroy materials or move to higher containment levels later. It notes the particular challenge of containment in facilities producing inactivated vaccine from wild poliovirus.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "dans les",
          "heading": false
        },
        {
          "term": "les activités",
          "heading": false
        },
        {
          "term": "mobilisation sociale",
          "heading": false
        },
        {
          "term": "tous les",
          "heading": false
        },
        {
          "term": "les pays",
          "heading": false
        },
        {
          "term": "poliovirus sauvage",
          "heading": false
        },
        {
          "term": "pour éradication",
          "heading": false
        },
        {
          "term": "les mesures",
          "heading": false
        }
      ],
      "extract": "36 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 d’ici à la certification mondiale. Dans tous les pays, l’élaboration de politiques à long terme pour la poliomyélite, notamment en ce qui concerne la vaccination systématique, créera de nouvelles demandes dans ce domaine d’activité. Il faut intensifier les efforts de mobilisation sociale dans les dernières zones d’endémie",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-038"
      ]
    },
    {
      "id": "page-039",
      "number": null,
      "title": "Page 39",
      "level": 1,
      "pageStart": 39,
      "pageEnd": 39,
      "labelStart": "37",
      "labelEnd": "37",
      "words": 767,
      "summary": {
        "text": "Opens the chapter on the role of partners, describing governments of endemic, recently endemic and polio-free countries as owners and beneficiaries of the initiative who contribute cash and in-kind resources. It then outlines the roles of the spearheading partners, WHO, providing technical leadership, coordination and surveillance support, and Rotary International, which has committed over US$ 500 million and mobilized volunteers through its PolioPlus programme. It begins describing the contributions of UNICEF and the US Centers for Disease Control and Prevention.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "activités éradication",
          "heading": false
        },
        {
          "term": "pour éradication",
          "heading": false
        },
        {
          "term": "les bureaux",
          "heading": false
        },
        {
          "term": "des gouvernements",
          "heading": false
        },
        {
          "term": "des pays",
          "heading": false
        },
        {
          "term": "des ressources",
          "heading": false
        },
        {
          "term": "poliomyélite est",
          "heading": false
        },
        {
          "term": "par des",
          "heading": false
        }
      ],
      "extract": "37 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 L e r ô l e d e s p a r t e n a i r e s 6 6 . 1 G o u v e r n e m e n t s Les gouvernements des pays où la poliomyélite est endémique ou l’était récemment ainsi que les pays exempts de la maladie sont les maîtres en même temps que les bénéficiaires de l’Initiative mondiale pour l’éradication de la poliomyélite, au titre de",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-039"
      ]
    },
    {
      "id": "page-040",
      "number": null,
      "title": "Page 40",
      "level": 1,
      "pageStart": 40,
      "pageEnd": 40,
      "labelStart": "38",
      "labelEnd": "38",
      "words": 772,
      "summary": {
        "text": "Describes the US Centers for Disease Control and Prevention's support, including funding for OPV, staff for surveillance and outbreak investigations and advanced virological expertise to trace virus origins. It covers international development agencies such as those of Germany, Canada, the United States, Japan and the United Kingdom, which had given or pledged US$ 1.76 billion, 59% of all funds for 1985–2005. It also notes that the Bill & Melinda Gates Foundation is the largest donor after the Rotary Foundation, with US$ 75 million committed.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "fondation des",
          "heading": false
        },
        {
          "term": "fondation rotary",
          "heading": false
        },
        {
          "term": "mobilisation des",
          "heading": false
        },
        {
          "term": "les partenaires",
          "heading": false
        },
        {
          "term": "pour les",
          "heading": false
        },
        {
          "term": "des pays",
          "heading": false
        },
        {
          "term": "pour éradication",
          "heading": false
        },
        {
          "term": "dans des",
          "heading": false
        }
      ],
      "extract": "38 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 CDC, lesquels apportent également des fonds pour l’achat du VPO nécessaire aux campagnes de vaccination de masse et fournissent toute une gamme de compétences techniques et un appui en laboratoire. Ils détachent en particulier du personnel pour la surveillance de la maladie aux niveaux mondial, régional et national et pour",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-040"
      ]
    },
    {
      "id": "page-041",
      "number": null,
      "title": "Page 41",
      "level": 1,
      "pageStart": 41,
      "pageEnd": 41,
      "labelStart": "39",
      "labelEnd": "39",
      "words": 779,
      "summary": {
        "text": "Describes a loan buy-down mechanism set up by the World Bank with foundations and Rotary to purchase polio vaccine for Nigeria and Pakistan, concessional loans from development banks, and private-sector fundraising. It covers international humanitarian organizations, with Red Cross and Red Crescent societies supporting campaigns and volunteer mobilization and the ICRC facilitating access to conflict zones. It notes that NGOs such as the Albert B. Sabin Vaccine Institute, Médecins sans Frontières and Save the Children support advocacy and have reached children in conflict-affected countries.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "des sociétés",
          "heading": false
        },
        {
          "term": "des ong",
          "heading": false
        },
        {
          "term": "des campagnes",
          "heading": false
        },
        {
          "term": "fondation des",
          "heading": false
        },
        {
          "term": "des activités",
          "heading": false
        },
        {
          "term": "banque mondiale",
          "heading": false
        },
        {
          "term": "dans des",
          "heading": false
        },
        {
          "term": "mener des",
          "heading": false
        }
      ],
      "extract": "39 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 Unies ont également aidé l’Initiative en collaborant avec la Banque mondiale à l’application d’un mécanisme financier de conversion de prêts en dons qui permettra d’acheter du vaccin antipoliomyélitique pour le Nigéria et le Pakistan. Banques de développement et organismes multilatéraux : Des institutions comme la Banque",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-041"
      ]
    },
    {
      "id": "page-042",
      "number": null,
      "title": "Page 42",
      "level": 1,
      "pageStart": 42,
      "pageEnd": 42,
      "labelStart": "40",
      "labelEnd": "40",
      "words": 190,
      "summary": {
        "text": "Describes the role of vaccine manufacturers in supplying enough quality-controlled polio vaccine on time, working with UNICEF and WHO on demand forecasts and production planning, and conducting research on products needed after certification.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pour les",
          "heading": false
        },
        {
          "term": "les plans",
          "heading": false
        },
        {
          "term": "industrie",
          "heading": false
        },
        {
          "term": "aux activités",
          "heading": false
        },
        {
          "term": "quantités",
          "heading": false
        },
        {
          "term": "vaccin",
          "heading": false
        },
        {
          "term": "voulu",
          "heading": false
        }
      ],
      "extract": "40 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 6 . 5 F a b r i c a n t s d e v a c c i n L’industrie du vaccin joue un rôle déterminant dans l’aide aux activités de vaccination systématique et aux activités de vaccination supplémentaires contre la poliomyélite en fournissant les quantités nécessaires de vaccin de qualité contrôlée. Les fabricants veillent à ce que des",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-042"
      ]
    },
    {
      "id": "page-043",
      "number": null,
      "title": "Page 43",
      "level": 1,
      "pageStart": 43,
      "pageEnd": 43,
      "labelStart": "41",
      "labelEnd": "41",
      "words": 718,
      "summary": {
        "text": "Opens the chapter on 2009 and beyond, the phase of stopping OPV worldwide, explaining that both long-term and time-limited activities will be needed after certification, though costs cannot yet be estimated. It describes long-term needs such as independent verification of poliovirus containment and management of monovalent OPV stockpiles. It outlines time-limited measures against vaccine-derived poliovirus, such as maintaining acute flaccid paralysis surveillance for at least two years after OPV cessation and possibly environmental sampling or pre-cessation campaigns.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "poliovirus circulants",
          "heading": false
        },
        {
          "term": "vpi pour",
          "heading": false
        },
        {
          "term": "des poliovirus",
          "heading": false
        },
        {
          "term": "poliovirus sauvage",
          "heading": false
        },
        {
          "term": "long terme",
          "heading": false
        },
        {
          "term": "circulants dérivés",
          "heading": false
        },
        {
          "term": "souche vaccinale",
          "heading": false
        },
        {
          "term": "confinement des",
          "heading": false
        }
      ],
      "extract": "41 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 2 0 0 9 e t a u - d e l à - l a p h a s e d ’ a r r ê t d e l a v a c c i n a t i o n p a r l e V P O d a n s l e m o n d e 7 C OMPTE tenu de l’expérience de l’éradication de la variole et des risques associés à la poursuite de l’utilisation du VPO, il est évident qu’il faut prévoir un dosage d’activités d’éradication à long",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-043"
      ]
    },
    {
      "id": "page-044",
      "number": null,
      "title": "Page 44",
      "level": 1,
      "pageStart": 44,
      "pageEnd": 44,
      "labelStart": "42",
      "labelEnd": "42",
      "words": 176,
      "summary": {
        "text": "Notes that partners supplying routine vaccines, such as GAVI, will be central to decisions on post-OPV vaccination, and that financial needs will depend on international decisions in 2005–2007 about OPV cessation, stockpiles and other polio vaccines.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "mondiale pour",
          "heading": false
        },
        {
          "term": "vaccination par",
          "heading": false
        },
        {
          "term": "vaccins",
          "heading": false
        },
        {
          "term": "arrêt",
          "heading": false
        },
        {
          "term": "des",
          "heading": false
        },
        {
          "term": "vpo",
          "heading": false
        },
        {
          "term": "les",
          "heading": false
        }
      ],
      "extract": "42 PLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008 fourniture de ces vaccins pour la vaccination systématique, comme l’Alliance mondiale pour les vaccins et la vaccination, devront jouer dans cette démarche un rôle central. Pour ce qui est des ressources, les incidences de la phase d’arrêt de la vaccination par le VPO dans le monde seront déterminées compte tenu des travaux",
      "extractCut": true,
      "blocks": [
        "library/10665-42988/blocks/prose-page-044"
      ]
    },
    {
      "id": "page-045",
      "number": null,
      "title": "Page 45",
      "level": 1,
      "pageStart": 45,
      "pageEnd": 45,
      "labelStart": "43",
      "labelEnd": "43",
      "words": 57,
      "summary": {
        "text": "The back cover listing WHO as a spearheading partner of the Global Polio Eradication Initiative, with its Geneva address and contact details.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "initiative mondiale",
          "heading": false
        },
        {
          "term": "pour éradication",
          "heading": false
        },
        {
          "term": "polioeradication",
          "heading": false
        }
      ],
      "extract": "43 GLOBAL POLIO ERADICATION INITIATIVE STRATEGIC PLAN 2004–2008 Partenaires principaux de l’Initiative mondiale pour l’éradication de la poliomyélite Organisation mondiale de la Santé Initiative mondiale pour l’éradication de la poliomyélite 20, avenue Appia CH-1211 Genève 27 Suisse Téléphone : (41 22) 791 2111 Télécopie : (41 22) 791 4193 Courriel : polioepi@who.int Site web : www.polioeradication.org OMS",
      "extractCut": false,
      "blocks": [
        "library/10665-42988/blocks/prose-page-045"
      ]
    }
  ],
  "checks": {
    "tocAlignment": {
      "listed_not_found": {
        "count": 15,
        "items": [
          "Sigles et acronymes",
          "Résumé",
          "But",
          "Objectifs et étapes",
          "Objectif Nº 1 : Interrompre la transmission du poliovirus",
          "Objectif Nº 2 : Parvenir à la certification de l’éradication mondiale de la poliomyélite",
          "Objectif Nº 3 : Mettre au point des produits pour la phase d’arrêt de la vaccination par le VPO dans le monde",
          "Objectif Nº 4 : Intégrer l’Initiative mondiale pour l’éradication de la poliomyélite",
          "Enjeux généraux",
          "Volonté et engagement politiques",
          "Pays et zones en proie à un conflit",
          "Le rôle des partenaires",
          "Donateurs et partenaires techniques",
          "Fabricants de vaccin",
          "2009 et au-delà - la phase d’arrêt de la vaccination par le VPO dans le monde"
        ]
      },
      "found_not_listed": {
        "count": 2,
        "items": [
          "5 Surveillance et laboratoires de haute qualité (voir aussi l’objectif N° 2) : Pour",
          "5 Appui au développement d’autres interventions de santé : Il s’agira surtout ici de"
        ]
      },
      "page_mismatch": {
        "count": 0,
        "items": []
      }
    },
    "figureSequenceGaps": [],
    "pageLabelConflicts": {
      "count": 1,
      "items": [
        "p36: pdf-labels 34, printed 34, contents 6"
      ]
    }
  },
  "withheld": false,
  "keywords": [
    {
      "term": "pour des",
      "heading": false
    },
    {
      "term": "poliomyélite les",
      "heading": false
    },
    {
      "term": "des poliovirus",
      "heading": false
    },
    {
      "term": "dans des",
      "heading": false
    },
    {
      "term": "des activités",
      "heading": false
    },
    {
      "term": "des pays",
      "heading": false
    },
    {
      "term": "mondiale pour",
      "heading": true
    },
    {
      "term": "par des",
      "heading": false
    },
    {
      "term": "pour éradication",
      "heading": true
    },
    {
      "term": "vpo pour",
      "heading": true
    },
    {
      "term": "que des",
      "heading": false
    },
    {
      "term": "poliomyélite qui",
      "heading": false
    }
  ],
  "pageLabels": [
    {
      "physical": 1,
      "label": "A",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 2,
      "label": "B",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 3,
      "label": "1",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 4,
      "label": "2",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 5,
      "label": "3",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 6,
      "label": "4",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 7,
      "label": "5",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 8,
      "label": "6",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 9,
      "label": "7",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 10,
      "label": "8",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 11,
      "label": "9",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 12,
      "label": "10",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 13,
      "label": "11",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 14,
      "label": "12",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 15,
      "label": "13",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 16,
      "label": "14",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 17,
      "label": "15",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 18,
      "label": "16",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 19,
      "label": "17",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 20,
      "label": "18",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 21,
      "label": "19",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 22,
      "label": "20",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 23,
      "label": "21",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 24,
      "label": "22",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 25,
      "label": "23",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 26,
      "label": "24",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 27,
      "label": "25",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 28,
      "label": "26",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 29,
      "label": "27",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 30,
      "label": "28",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 31,
      "label": "29",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 32,
      "label": "30",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 33,
      "label": "31",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 34,
      "label": "32",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 35,
      "label": "33",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 36,
      "label": "34",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 37,
      "label": "35",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 38,
      "label": "36",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 39,
      "label": "37",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 40,
      "label": "38",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 41,
      "label": "39",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 42,
      "label": "40",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 43,
      "label": "41",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 44,
      "label": "42",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 45,
      "label": "43",
      "source": "printed",
      "confidence": 0.85
    }
  ],
  "figures": [
    {
      "kind": "figure",
      "number": "1",
      "title": "Principales cibles pour interrompre la transmission du poliovirus (2004-2005), parvenir à la certification mondiale et intégrer l’Initiative mondiale pour l’éradication de la poliomyélite (2006-2008), et pendant la phase d’arrêt de la vaccination par le VPO dans le monde (2009 et au-delà)",
      "page": 8,
      "pageLabel": "6",
      "confidence": 0.9,
      "evidence": [
        "referenced",
        "in-sequence",
        "graphic"
      ]
    },
    {
      "kind": "figure",
      "number": "2",
      "title": "Poliovirus sauvage*, 1er janvier 2003 – 9 décembre 2003",
      "page": 12,
      "pageLabel": "10",
      "confidence": 0.9,
      "evidence": [
        "referenced",
        "in-sequence",
        "graphic"
      ]
    },
    {
      "kind": "figure",
      "number": "3",
      "title": "Indicateurs de performance pour la PFA 1er janvier 2003 - 25 novembre 2003",
      "page": 23,
      "pageLabel": "21",
      "confidence": 0.9,
      "evidence": [
        "referenced",
        "in-sequence",
        "graphic"
      ]
    },
    {
      "kind": "figure",
      "number": "4",
      "title": "Réseau mondial de laboratoires pour l’éradication de la poliomyélite, 2002",
      "page": 23,
      "pageLabel": "21",
      "confidence": 0.9,
      "evidence": [
        "referenced",
        "in-sequence",
        "graphic"
      ]
    }
  ],
  "images": [
    {
      "id": "img-p001-2",
      "file": "images/img-p001-2.webp",
      "page": 1,
      "narratives": {
        "en": "Blue-toned cover photograph of a young child, mouth open, receiving drops of oral vaccine from a dropper held by an adult's hand, with other people blurred in the background.",
        "ar": "صورة غلاف بدرجات اللون الأزرق لطفل صغير فاتح فمه يتلقى قطرات من لقاح فموي من قطّارة تمسكها يد شخص بالغ، ويظهر أشخاص آخرون بشكل ضبابي في الخلفية.",
        "zh": "蓝色调封面照片：一名幼儿张着嘴，正从成人手持的滴管中接受口服疫苗滴剂，背景中其他人物模糊。",
        "es": "Fotografía de portada en tonos azules de un niño pequeño con la boca abierta que recibe gotas de vacuna oral de un cuentagotas sostenido por la mano de un adulto; al fondo, otras personas desenfocadas.",
        "fr": "Photographie de couverture aux tons bleus d’un jeune enfant, bouche ouverte, recevant des gouttes de vaccin oral d’un compte-gouttes tenu par la main d’un adulte, avec d’autres personnes floues à l’arrière-plan.",
        "ru": "Фотография на обложке в синих тонах: маленький ребёнок с открытым ртом получает капли пероральной вакцины из пипетки в руке взрослого; на заднем плане размыты другие люди."
      },
      "state": "draft"
    },
    {
      "id": "vfig-p008",
      "file": "figures/vfig-p008.webp",
      "page": 8,
      "shows": [
        "Figure 1"
      ],
      "narratives": {
        "en": "Figure 1 is a timeline with year headings 2004, 2005, 2006, 2007, 2008 and “2009 et au-delà”, and seven horizontal bars starting in 2004 for the main targets: interrompre la transmission du poliovirus; parvenir à la certification – surveillance type dans tous les pays; mener à bien la vaccination supplémentaire; achever la phase II du confinement en laboratoire; certifier l’éradication mondiale; intégrer les activités à long terme et les ressources humaines de l’éradication de la poliomyélite; and passage à une politique à long terme de vaccination antipoliomyélitique. The bars get progressively longer: the first ends around 2005, the laboratory containment bar around 2007, global certification around 2008, and the last two extend into 2009 and beyond.",
        "ar": "الشكل 1 خط زمني بعناوين السنوات 2004 و2005 و2006 و2007 و2008 و«2009 وما بعدها»، وسبعة أشرطة أفقية تبدأ في 2004 للغايات الرئيسية: وقف سراية فيروس شلل الأطفال؛ وبلوغ الإشهاد – ترصد وفق المعايير في جميع البلدان؛ وإتمام التمنيع التكميلي؛ وإنجاز المرحلة الثانية من الاحتواء المختبري؛ والإشهاد على الاستئصال على الصعيد العالمي؛ وإدماج الأنشطة الطويلة الأجل والموارد البشرية لاستئصال شلل الأطفال؛ والانتقال إلى سياسة طويلة الأجل للتطعيم ضد شلل الأطفال. وتطول الأشرطة تدريجيًا: ينتهي الأول نحو 2005، وشريط الاحتواء المختبري نحو 2007، والإشهاد العالمي نحو 2008، ويمتد الشريطان الأخيران إلى 2009 وما بعدها.",
        "zh": "图1为时间轴，年份标题为2004、2005、2006、2007、2008和“2009年及以后”，七条水平条形均从2004年开始，代表主要目标：阻断脊灰病毒传播；实现认证——所有国家达到认证标准的监测；完成补充免疫；完成第二阶段实验室封存；全球消灭认证；整合消灭脊灰的长期活动和人力资源；以及过渡到长期脊灰疫苗接种政策。条形逐渐变长：第一条约在2005年结束，实验室封存约在2007年，全球认证约在2008年，最后两条延伸至2009年及以后。",
        "es": "La figura 1 es una cronología con los años 2004, 2005, 2006, 2007, 2008 y «2009 y después», y siete barras horizontales que empiezan en 2004 para las metas principales: interrumpir la transmisión del poliovirus; lograr la certificación – vigilancia de calidad de certificación en todos los países; completar la inmunización suplementaria; finalizar la fase II de contención en laboratorio; certificar la erradicación mundial; integrar las actividades a largo plazo y los recursos humanos de la erradicación de la poliomielitis; y pasar a una política a largo plazo de vacunación antipoliomielítica. Las barras se alargan progresivamente: la primera termina hacia 2005, la de contención en laboratorio hacia 2007, la certificación mundial hacia 2008 y las dos últimas se extienden hasta 2009 y después.",
        "fr": "La figure 1 est une frise chronologique avec les années 2004, 2005, 2006, 2007, 2008 et « 2009 et au-delà », et sept barres horizontales partant de 2004 pour les principales cibles : interrompre la transmission du poliovirus ; parvenir à la certification – surveillance type dans tous les pays ; mener à bien la vaccination supplémentaire ; achever la phase II du confinement en laboratoire ; certifier l’éradication mondiale ; intégrer les activités à long terme et les ressources humaines de l’éradication de la poliomyélite ; et passage à une politique à long terme de vaccination antipoliomyélitique. Les barres s’allongent progressivement : la première se termine vers 2005, celle du confinement en laboratoire vers 2007, la certification mondiale vers 2008, et les deux dernières se prolongent en 2009 et au-delà.",
        "ru": "Рисунок 1 — временная шкала с заголовками 2004, 2005, 2006, 2007, 2008 и «2009 и далее» и семью горизонтальными полосами, начинающимися в 2004 г., для основных целей: прерывание передачи полиовируса; достижение сертификации — эпиднадзор сертификационного уровня во всех странах; завершение дополнительной иммунизации; завершение II фазы лабораторной изоляции; сертификация глобальной ликвидации; интеграция долгосрочных мероприятий и кадровых ресурсов ликвидации полиомиелита; переход к долгосрочной политике вакцинации против полиомиелита. Полосы постепенно удлиняются: первая заканчивается около 2005 г., лабораторная изоляция — около 2007 г., глобальная сертификация — около 2008 г., а две последние продолжаются в 2009 г. и далее."
      },
      "state": "draft"
    },
    {
      "id": "img-p012-1",
      "file": "images/img-p012-1.webp",
      "page": 12,
      "narratives": {
        "en": "Map of Africa, the Middle East and South Asia (the map in Figure 2) with endemic countries shaded pale yellow — Nigeria, Niger, Egypt, Pakistan, Afghanistan and India — and red and blue dots marking wild poliovirus cases. Dots cluster in northern Nigeria and across northern India and Pakistan, with a dense red cluster in northern India.",
        "ar": "خريطة لأفريقيا والشرق الأوسط وجنوب آسيا (خريطة الشكل 2) تظهر فيها البلدان الموطونة مظللة بالأصفر الفاتح — نيجيريا والنيجر ومصر وباكستان وأفغانستان والهند — مع نقاط حمراء وزرقاء تمثل حالات فيروس شلل الأطفال البري. وتتجمع النقاط في شمال نيجيريا وفي أنحاء شمال الهند وباكستان، مع تجمع أحمر كثيف في شمال الهند.",
        "zh": "非洲、中东和南亚地图（图2中的地图），流行国家以浅黄色标示——尼日利亚、尼日尔、埃及、巴基斯坦、阿富汗和印度——红色和蓝色圆点表示野生脊灰病毒病例。圆点集中在尼日利亚北部以及印度北部和巴基斯坦各地，印度北部有密集的红点聚集。",
        "es": "Mapa de África, Oriente Medio y Asia meridional (el mapa de la figura 2) con los países endémicos sombreados en amarillo pálido —Nigeria, Níger, Egipto, Pakistán, Afganistán e India— y puntos rojos y azules que marcan casos de poliovirus salvaje. Los puntos se concentran en el norte de Nigeria y en el norte de la India y Pakistán, con un denso grupo rojo en el norte de la India.",
        "fr": "Carte de l’Afrique, du Moyen-Orient et de l’Asie du Sud (la carte de la figure 2) où les pays d’endémie sont ombrés en jaune pâle — Nigéria, Niger, Égypte, Pakistan, Afghanistan et Inde — avec des points rouges et bleus marquant les cas de poliovirus sauvage. Les points se concentrent dans le nord du Nigéria et dans le nord de l’Inde et du Pakistan, avec un groupe rouge dense dans le nord de l’Inde.",
        "ru": "Карта Африки, Ближнего Востока и Южной Азии (карта рисунка 2), на которой эндемичные страны закрашены бледно-жёлтым — Нигерия, Нигер, Египет, Пакистан, Афганистан и Индия, — а красные и синие точки обозначают случаи дикого полиовируса. Точки сосредоточены на севере Нигерии, а также на севере Индии и в Пакистане, с плотным красным скоплением на севере Индии."
      },
      "state": "draft"
    },
    {
      "id": "vfig-p012",
      "file": "figures/vfig-p012.webp",
      "page": 12,
      "shows": [
        "Figure 2"
      ],
      "narratives": {
        "en": "Figure 2 is a map of wild poliovirus cases from 1 January to 9 December 2003 covering Africa, the Middle East and South Asia. Dots show wild poliovirus type 1 (red), type 3 (blue) and types 1 and 3 (black); endemic countries are shaded yellow, and green circles mark importations in West and Central Africa and the Middle East. Cases concentrate in northern Nigeria, Niger, Pakistan, Afghanistan and northern India.",
        "ar": "الشكل 2 خريطة لحالات فيروس شلل الأطفال البري من 1 كانون الثاني/يناير إلى 9 كانون الأول/ديسمبر 2003 تغطي أفريقيا والشرق الأوسط وجنوب آسيا. تبيّن النقاط فيروس شلل الأطفال البري من النمط 1 (أحمر) والنمط 3 (أزرق) والنمطين 1 و3 (أسود)؛ والبلدان الموطونة مظللة بالأصفر، والدوائر الخضراء تشير إلى الحالات الوافدة في غرب أفريقيا ووسطها والشرق الأوسط. وتتركز الحالات في شمال نيجيريا والنيجر وباكستان وأفغانستان وشمال الهند.",
        "zh": "图2为2003年1月1日至12月9日野生脊灰病毒病例地图，覆盖非洲、中东和南亚。圆点表示1型野生脊灰病毒（红色）、3型（蓝色）及1型和3型（黑色）；流行国家以黄色标示，绿色圆圈标出西非、中非和中东的输入病例。病例集中在尼日利亚北部、尼日尔、巴基斯坦、阿富汗和印度北部。",
        "es": "La figura 2 es un mapa de casos de poliovirus salvaje entre el 1 de enero y el 9 de diciembre de 2003 que abarca África, Oriente Medio y Asia meridional. Los puntos indican poliovirus salvaje de tipo 1 (rojo), tipo 3 (azul) y tipos 1 y 3 (negro); los países endémicos están sombreados en amarillo y los círculos verdes señalan importaciones en África occidental y central y en Oriente Medio. Los casos se concentran en el norte de Nigeria, Níger, Pakistán, Afganistán y el norte de la India.",
        "fr": "La figure 2 est une carte des cas de poliovirus sauvage du 1er janvier au 9 décembre 2003 couvrant l’Afrique, le Moyen-Orient et l’Asie du Sud. Les points indiquent le poliovirus sauvage de type 1 (rouge), de type 3 (bleu) et des types 1 et 3 (noir) ; les pays d’endémie sont ombrés en jaune et des cercles verts signalent des importations en Afrique de l’Ouest et du Centre et au Moyen-Orient. Les cas se concentrent dans le nord du Nigéria, au Niger, au Pakistan, en Afghanistan et dans le nord de l’Inde.",
        "ru": "Рисунок 2 — карта случаев дикого полиовируса с 1 января по 9 декабря 2003 г., охватывающая Африку, Ближний Восток и Южную Азию. Точки обозначают дикий полиовирус типа 1 (красные), типа 3 (синие) и типов 1 и 3 (чёрные); эндемичные страны закрашены жёлтым, зелёные круги отмечают завозные случаи в Западной и Центральной Африке и на Ближнем Востоке. Случаи сосредоточены на севере Нигерии, в Нигере, Пакистане, Афганистане и на севере Индии."
      },
      "state": "draft"
    },
    {
      "id": "img-p023-1",
      "file": "images/img-p023-1.webp",
      "page": 23,
      "narratives": {
        "en": "World map (top panel of Figure 3) colouring countries by an AFP surveillance rate indicator: most of Africa, Asia, the Russian Federation and Latin America are dark green (≥1), while Brazil and several European and Asian countries are yellow (0.5–1) and Australia, Algeria and some European countries are red (<0.5). North America, much of western Europe and Japan are light grey, indicating no AFP surveillance.",
        "ar": "خريطة عالمية (اللوحة العليا من الشكل 3) تلوّن البلدان حسب مؤشر لمعدل ترصد الشلل الرخو الحاد: معظم أفريقيا وآسيا والاتحاد الروسي وأمريكا اللاتينية بالأخضر الداكن (≥1)، في حين أن البرازيل وعدة بلدان أوروبية وآسيوية بالأصفر (0.5–1)، وأستراليا والجزائر وبعض البلدان الأوروبية بالأحمر (<0.5). وتظهر أمريكا الشمالية ومعظم أوروبا الغربية واليابان بالرمادي الفاتح، ما يدل على عدم وجود ترصد للشلل الرخو الحاد.",
        "zh": "世界地图（图3上图），按急性弛缓性麻痹监测率指标为各国着色：非洲、亚洲、俄罗斯联邦和拉丁美洲大部分地区为深绿色（≥1），巴西及若干欧洲和亚洲国家为黄色（0.5–1），澳大利亚、阿尔及利亚和部分欧洲国家为红色（<0.5）。北美、西欧大部分地区和日本为浅灰色，表示无急性弛缓性麻痹监测。",
        "es": "Mapa mundial (panel superior de la figura 3) que colorea los países según un indicador de tasa de vigilancia de la PFA: la mayor parte de África, Asia, la Federación de Rusia y América Latina aparece en verde oscuro (≥1), mientras que Brasil y varios países europeos y asiáticos están en amarillo (0,5–1) y Australia, Argelia y algunos países europeos en rojo (<0,5). América del Norte, gran parte de Europa occidental y el Japón aparecen en gris claro, lo que indica ausencia de vigilancia de la PFA.",
        "fr": "Carte du monde (panneau supérieur de la figure 3) colorant les pays selon un indicateur de taux de surveillance de la PFA : la majeure partie de l’Afrique, de l’Asie, de la Fédération de Russie et de l’Amérique latine est en vert foncé (≥1), tandis que le Brésil et plusieurs pays d’Europe et d’Asie sont en jaune (0,5–1) et l’Australie, l’Algérie et certains pays européens en rouge (<0,5). L’Amérique du Nord, une grande partie de l’Europe occidentale et le Japon sont en gris clair, indiquant l’absence de surveillance de la PFA.",
        "ru": "Карта мира (верхняя панель рисунка 3), на которой страны окрашены по показателю частоты эпиднадзора за ОВП: бóльшая часть Африки, Азии, Российской Федерации и Латинской Америки — тёмно-зелёная (≥1), Бразилия и ряд стран Европы и Азии — жёлтые (0,5–1), Австралия, Алжир и некоторые европейские страны — красные (<0,5). Северная Америка, бóльшая часть Западной Европы и Япония — светло-серые, что означает отсутствие эпиднадзора за ОВП."
      },
      "state": "draft"
    },
    {
      "id": "img-p023-2",
      "file": "images/img-p023-2.webp",
      "page": 23,
      "narratives": {
        "en": "World map (bottom panel of Figure 3) colouring countries by the rate of adequate stool specimen collection: most of Africa, Asia and the Russian Federation are dark green (≥80%), Brazil, Argentina, Mongolia and several African and European countries are yellow (60%–80%), and Australia, Spain and some other European and South American countries are red (<60%). North America, much of western Europe and Japan are light grey (no AFP surveillance).",
        "ar": "خريطة عالمية (اللوحة السفلى من الشكل 3) تلوّن البلدان حسب معدل جمع عينات البراز الكافية: معظم أفريقيا وآسيا والاتحاد الروسي بالأخضر الداكن (≥80%)، والبرازيل والأرجنتين ومنغوليا وعدة بلدان أفريقية وأوروبية بالأصفر (60%–80%)، وأستراليا وإسبانيا وبعض البلدان الأوروبية وبلدان أمريكا الجنوبية الأخرى بالأحمر (<60%). وتظهر أمريكا الشمالية ومعظم أوروبا الغربية واليابان بالرمادي الفاتح (لا يوجد ترصد للشلل الرخو الحاد).",
        "zh": "世界地图（图3下图），按合格粪便标本采集率为各国着色：非洲、亚洲和俄罗斯联邦大部分地区为深绿色（≥80%），巴西、阿根廷、蒙古及若干非洲和欧洲国家为黄色（60%–80%），澳大利亚、西班牙及其他一些欧洲和南美国家为红色（<60%）。北美、西欧大部分地区和日本为浅灰色（无急性弛缓性麻痹监测）。",
        "es": "Mapa mundial (panel inferior de la figura 3) que colorea los países según la tasa de recogida de muestras de heces adecuadas: la mayor parte de África, Asia y la Federación de Rusia aparece en verde oscuro (≥80%); Brasil, Argentina, Mongolia y varios países africanos y europeos en amarillo (60%–80%); y Australia, España y algunos otros países europeos y sudamericanos en rojo (<60%). América del Norte, gran parte de Europa occidental y el Japón están en gris claro (sin vigilancia de la PFA).",
        "fr": "Carte du monde (panneau inférieur de la figure 3) colorant les pays selon le taux de collecte d’échantillons de selles adéquats : la majeure partie de l’Afrique, de l’Asie et de la Fédération de Russie est en vert foncé (≥80 %) ; le Brésil, l’Argentine, la Mongolie et plusieurs pays africains et européens sont en jaune (60 %–80 %) ; l’Australie, l’Espagne et quelques autres pays d’Europe et d’Amérique du Sud sont en rouge (<60 %). L’Amérique du Nord, une grande partie de l’Europe occidentale et le Japon sont en gris clair (pas de surveillance de la PFA).",
        "ru": "Карта мира (нижняя панель рисунка 3), на которой страны окрашены по доле адекватно собранных образцов стула: бóльшая часть Африки, Азии и Российской Федерации — тёмно-зелёная (≥80%), Бразилия, Аргентина, Монголия и ряд стран Африки и Европы — жёлтые (60%–80%), Австралия, Испания и некоторые другие страны Европы и Южной Америки — красные (<60%). Северная Америка, бóльшая часть Западной Европы и Япония — светло-серые (нет эпиднадзора за ОВП)."
      },
      "state": "draft"
    },
    {
      "id": "vfig-p023",
      "file": "figures/vfig-p023.webp",
      "page": 23,
      "shows": [
        "Figure 3",
        "Figure 4"
      ],
      "narratives": {
        "en": "Figure 3 shows two world maps of AFP surveillance performance indicators, 1 January–25 November 2003: the top map is coloured by rate (<0.5 red, 0.5–1 yellow, ≥1 green) and the bottom map by adequate stool collection rate (<60% red, 60%–80% yellow, ≥80% green), with grey for no AFP surveillance; most of Africa and Asia are green, and North America and much of western Europe are grey. Figure 4 is a world map of the Global Polio Laboratory Network, 2002, marking specialized reference laboratories (blue stars, e.g. in the United States, Europe, India and Japan), regional reference laboratories (green circles) and national/subnational laboratories (red triangles), the latter densest in Europe, South and East Asia and Africa.",
        "ar": "يعرض الشكل 3 خريطتين عالميتين لمؤشرات أداء ترصد الشلل الرخو الحاد، 1 كانون الثاني/يناير – 25 تشرين الثاني/نوفمبر 2003: الخريطة العليا ملوّنة حسب المعدل (<0.5 أحمر، 0.5–1 أصفر، ≥1 أخضر)، والسفلى حسب معدل جمع عينات البراز الكافية (<60% أحمر، 60%–80% أصفر، ≥80% أخضر)، مع الرمادي لعدم وجود ترصد؛ ومعظم أفريقيا وآسيا بالأخضر، وأمريكا الشمالية ومعظم أوروبا الغربية بالرمادي. والشكل 4 خريطة عالمية للشبكة العالمية لمختبرات شلل الأطفال، 2002، تحدد المختبرات المرجعية المتخصصة (نجوم زرقاء، مثلاً في الولايات المتحدة وأوروبا والهند واليابان)، والمختبرات المرجعية الإقليمية (دوائر خضراء)، والمختبرات الوطنية/دون الوطنية (مثلثات حمراء) الأكثر كثافة في أوروبا وجنوب آسيا وشرقها وأفريقيا.",
        "zh": "图3显示2003年1月1日至11月25日急性弛缓性麻痹监测绩效指标的两幅世界地图：上图按发病率着色（<0.5红色，0.5–1黄色，≥1绿色），下图按合格粪便标本采集率着色（<60%红色，60%–80%黄色，≥80%绿色），灰色表示无监测；非洲和亚洲大部分地区为绿色，北美和西欧大部分地区为灰色。图4为2002年全球脊灰实验室网络世界地图，标出专业参比实验室（蓝色星形，例如美国、欧洲、印度和日本）、区域参比实验室（绿色圆点）和国家/次国家实验室（红色三角形），后者在欧洲、南亚、东亚和非洲最为密集。",
        "es": "La figura 3 muestra dos mapas mundiales de indicadores de desempeño de la vigilancia de la PFA, del 1 de enero al 25 de noviembre de 2003: el superior se colorea según la tasa (<0,5 rojo, 0,5–1 amarillo, ≥1 verde) y el inferior según la tasa de recogida de muestras de heces adecuadas (<60% rojo, 60%–80% amarillo, ≥80% verde), con gris para ausencia de vigilancia; la mayor parte de África y Asia aparece en verde, y América del Norte y gran parte de Europa occidental en gris. La figura 4 es un mapa mundial de la Red Mundial de Laboratorios de Poliomielitis, 2002, que señala los laboratorios de referencia especializados (estrellas azules, p. ej., en los Estados Unidos, Europa, la India y el Japón), los laboratorios de referencia regionales (círculos verdes) y los laboratorios nacionales/subnacionales (triángulos rojos), estos últimos más densos en Europa, Asia meridional y oriental y África.",
        "fr": "La figure 3 présente deux cartes du monde des indicateurs de performance de la surveillance de la PFA, du 1er janvier au 25 novembre 2003 : la carte du haut est colorée selon le taux (<0,5 rouge, 0,5–1 jaune, ≥1 vert) et celle du bas selon le taux de collecte d’échantillons de selles adéquats (<60 % rouge, 60 %–80 % jaune, ≥80 % vert), le gris indiquant l’absence de surveillance ; la majeure partie de l’Afrique et de l’Asie est en vert, l’Amérique du Nord et une grande partie de l’Europe occidentale en gris. La figure 4 est une carte du monde du Réseau mondial de laboratoires pour l’éradication de la poliomyélite, 2002, indiquant les laboratoires de référence spécialisés (étoiles bleues, par ex. aux États-Unis, en Europe, en Inde et au Japon), les laboratoires de référence régionaux (cercles verts) et les laboratoires nationaux/sous-nationaux (triangles rouges), ces derniers plus denses en Europe, en Asie du Sud et de l’Est et en Afrique.",
        "ru": "На рисунке 3 представлены две карты мира показателей эффективности эпиднадзора за ОВП с 1 января по 25 ноября 2003 г.: верхняя окрашена по частоте (<0,5 — красный, 0,5–1 — жёлтый, ≥1 — зелёный), нижняя — по доле адекватно собранных образцов стула (<60% — красный, 60%–80% — жёлтый, ≥80% — зелёный), серым показано отсутствие эпиднадзора; бóльшая часть Африки и Азии зелёная, Северная Америка и бóльшая часть Западной Европы — серые. Рисунок 4 — карта мира Глобальной сети лабораторий по полиомиелиту, 2002 г., с указанием специализированных референс-лабораторий (синие звёзды, например в США, Европе, Индии и Японии), региональных референс-лабораторий (зелёные круги) и национальных/субнациональных лабораторий (красные треугольники), которые наиболее плотно расположены в Европе, Южной и Восточной Азии и Африке."
      },
      "state": "draft"
    }
  ],
  "coverage": [
    {
      "kind": "contents",
      "state": "not-extracted",
      "note": "split one section per page; no contents was trusted"
    },
    {
      "kind": "sections",
      "state": "partial",
      "count": 45,
      "note": "one per page, not by heading"
    },
    {
      "kind": "figures",
      "state": "found",
      "count": 7
    },
    {
      "kind": "tables",
      "state": "not-extracted"
    },
    {
      "kind": "references",
      "state": "none",
      "note": "no such heading in the text"
    },
    {
      "kind": "glossary",
      "state": "none",
      "note": "no such heading in the text"
    },
    {
      "kind": "footnotes",
      "state": "not-extracted"
    },
    {
      "kind": "summaries",
      "state": "found",
      "count": 45,
      "note": "45 of 45 sections"
    }
  ],
  "links": {
    "repo": "litlfred/who-iris",
    "branch": "main",
    "dir": "library/10665-42988"
  }
}
